US Patent 8105604 WT1 modified peptide
All edits
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+314 characters)
Article
Patent abstract
The present invention discloses a cancer antigen peptide comprising the following amino acid sequence: Cys Tyr Thr Trp Asn Gln Met Asn Leu (Sequence ID No. 3), a cancer vaccine having this for its active ingredient, and a DNA vaccine having for its active ingredient DNA that codes for this peptide.
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Haruo Sugiyama0
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08105604 WT1 modified peptide US Patent 8105604 WT1 modified peptide
Infobox
Patent Number
081056040
Patent Number
81056040
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
081056040
Date of Patent
January 31, 2012
0Patent Application Number
125526600
Date Filed
September 2, 2009
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08105604 WT1 modified peptide
Infobox
Is a
Patent jurisdiction
Patent number
08105604
Date of patent
January 31, 2012
Patent application number
12552660
Date Filed
September 2, 2009
Patent primary examiner
Find more entities like US Patent 8105604 WT1 modified peptide
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.